Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

38 results about "O-Antigens" patented technology

O-antigens (the outer carbohydrates) are the most variable portion of the LPS molecule, imparting the antigenic specificity. In contrast, lipid A is the most conserved part. However, lipid A composition also may vary (e.g., in number and nature of acyl chains even within or between genera).

Nucleotide specific for shigella bodyii 10 O-antigen

The invention provides a nucleotide specific for shigella bodyii 10 O-antigen, which is the total nucleotide sequence of the gene cluster for controlling the synthesis of O-antigens in shigella bodyii 10, e.g. isolated nucleotide represented by SEQ ID No:1, with overall length of 13402 bases, or nucleotide of SEQ ID No:1 including one or more inserted, deleted or substituted bases and sustains the isolated nucleotide functions, it also includes the oligonucleotides of wzx gines in the O-antigen gene cluster originating from the shigella bodyii 10, and genes and wzy genes having similar functions with wzx, and genes having similar functions with wzy genes or wzy genes or orf 8 genes with unknown functions. The invention proves the high specifity of oligonucleotides for shigella bodyii 10 O-antigen through PCR. A method for detecting and identifying shigella bodyii 10 in human body and the environment by means of the oligonucleotide according to the invention is also disclosed.
Owner:NANKAI UNIV

Nucleotide specific for escherichia coli 0141 O-antigen

The invention provides a nucleotide specific for Escherichia coli 0141 O-antigen, which is the total nucleotide sequence of the gene cluster for controlling the synthesis of O-antigens in Escherichia 0141, e.g. isolated nucleotide represented by SEQ ID No:1, with overall length of 15601 bases, or nucleotide of SEQ ID No:1 including one or more inserted, deleted or substituted bases and sustains the isolated nucleotide functions, it also includes the oligonucleotides of glycosyl transferase genes and oligosaccharide unit treatment genes in the O-antigen gene cluster originated from Escherichia coli 0141. The invention proves the high specifity of oligonucleotides for Escherichia coli 0141 O-antigen through PCR. A method for detecting and identifying Escherichia coli 0141 in human body and the environment by means of the oligonucleotide according to the invention is also disclosed.
Owner:NANKAI UNIV

Nucleotide specific to vibrio cholerae O6, O4, O7 and O15 and application of nucleotide

The invention relates to a nucleotide specific to vibrio cholerae O antigens and application of the nucleotide, wherein the nucleotide comprises 1) at least one of nucleotides as shown in SEQ ID NO: 1-8; and 2) at least one of nucleotides supplementary with the nucleotides as shown in SEQ ID NO: 1-8. The nucleotides can be used for preparing a PCR kit and a gene chip for detecting vibrio cholerae. The nucleotide specific to vibrio cholerae O antigens disclosed by the invention as well as the PCR kit and the gene chip containing the nucleotide is strong in practicability; the PCR kit is simple and convenient in preparation method, short in detection cycle, rapid in speed, strong in operability and easy in industrial production, while the PCR kit is relatively low in detection cost; and the nucleotide is high in accuracy and high in sensitivity.
Owner:NANKAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products